Journey Medical (DERM) Gains from Investment Securities: 2020-2025
Historic Gains from Investment Securities for Journey Medical (DERM) over the last 3 years, with Mar 2025 value amounting to $2.8 million.
- Journey Medical's Gains from Investment Securities rose 5.72% to $2.8 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.8 million, marking a year-over-year increase of 5.72%. This contributed to the annual value of $125,000 for FY2024, which is 30.94% down from last year.
- As of Q1 2025, Journey Medical's Gains from Investment Securities stood at $2.8 million, which was up 13,355.11% from $21,000 recorded in Q4 2024.
- In the past 5 years, Journey Medical's Gains from Investment Securities registered a high of $3.3 million during Q2 2022, and its lowest value of -$352,425 during Q3 2022.
- Over the past 3 years, Journey Medical's median Gains from Investment Securities value was $78,000 (recorded in 2023), while the average stood at $814,471.
- Per our database at Business Quant, Journey Medical's Gains from Investment Securities slumped by 98.96% in 2023 and then skyrocketed by 38,081.73% in 2024.
- Quarterly analysis of 5 years shows Journey Medical's Gains from Investment Securities stood at $1,000 in 2021, then surged by 14,800.00% to $149,000 in 2022, then plummeted by 35.57% to $96,000 in 2023, then plummeted by 78.12% to $21,000 in 2024, then increased by 5.72% to $2.8 million in 2025.
- Its Gains from Investment Securities was $2.8 million in Q1 2025, compared to $21,000 in Q4 2024 and $1,000 in Q3 2024.